The future of direct-to-consumer clinical genetic tests

Nat Rev Genet. 2011 Jun 1;12(7):511-5. doi: 10.1038/nrg3026.

Abstract

In light of the meeting of the US Food and Drug Administration (FDA) in March 2011 to discuss the regulation of clinical direct-to-consumer (DTC) genetic tests, we have invited five experts to consider the best means of overseeing the ordering and interpretation of these tests. Should these tests be regulated? If so, who, if anyone, should communicate results to consumers?

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Clinical Laboratory Techniques / trends
  • Commerce / methods
  • Commerce / trends
  • Communication
  • Community Participation / trends*
  • Genetic Testing / legislation & jurisprudence
  • Genetic Testing / methods
  • Genetic Testing / trends*
  • Humans
  • Physician-Patient Relations
  • United States
  • United States Food and Drug Administration / legislation & jurisprudence
  • United States Food and Drug Administration / trends